Literature DB >> 34450471

Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users.

Ofir Livne1, Dvora Shmulewitz2, Malka Stohl3, Zachary Mannes1, Efrat Aharonovich2, Deborah Hasin4.   

Abstract

BACKGROUND: In DSM-5, definitions of substance use disorders (SUD) were changed considerably from DSM-IV, yet little is known about how well DSM-IV and DSM-5 SUD diagnoses agree among substance users. Because data from many studies are based on DSM-IV diagnostic criteria, understanding the agreement between DSM-5 and DSM-IV SUD diagnoses and reasons for discordance between these diagnoses is crucial for comparing results across studies. MEASUREMENTS: Prevalences and chance-corrected agreement of DSM-5 SUD and DSM-IV substance dependence were evaluated in 588 substance users in a suburban inpatient addiction program and an urban medical center, using a semi-structured interview (PRISM-5). Alcohol, tobacco, cannabis, cocaine, heroin, opioid, sedative, and stimulant use disorders were examined. Cohen's kappa was used to assess agreement between DSM-5 and DSM-IV SUD (abuse or dependence), DSM-5 SUD and DSM-IV dependence, and DSM-5 moderate/severe SUD and DSM-IV dependence.
RESULTS: Agreement between DSM-5 and DSM-IV SUD was excellent for all substances (κ = 0.84-0.99), except for cannabis and tobacco (κ = 0.75; 0.80, respectively). The most common reason for diagnostic discrepancies was a positive DSM-5 SUD diagnosis but no DSM-IV diagnosis, due to the lowered DSM-5 SUD threshold. Agreement between DSM-5 SUD and DSM-IV dependence was excellent for all substances (κ = 0.88-0.94), except for alcohol, tobacco, and cannabis (κ = 0.63-0.75). Agreement between moderate/severe DSM-5 SUD and DSM-IV dependence was excellent across all substances.
CONCLUSION: While care should be used in interpreting results of studies using different methods, studies relying on DSM-IV or DSM-5 SUD diagnostic criteria offer similar information and thus can be compared when accumulating a body of evidence.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Addiction; DSM-5 and DSM-IV agreement; PRISM-5; Substance use disorder

Mesh:

Substances:

Year:  2021        PMID: 34450471      PMCID: PMC8977110          DOI: 10.1016/j.drugalcdep.2021.108958

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  42 in total

1.  Toward DSM-V: mapping the alcohol use disorder continuum in college students.

Authors:  Brett T Hagman; Amy M Cohn
Journal:  Drug Alcohol Depend       Date:  2011-04-22       Impact factor: 4.492

Review 2.  Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking.

Authors:  Richard Saitz
Journal:  Drug Alcohol Rev       Date:  2010-11

3.  DSM-5--the future arrived.

Authors:  David J Kupfer; Emily A Kuhl; Darrel A Regier
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

Review 4.  Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).

Authors:  Deborah Hasin; Mark L Hatzenbuehler; Katherine Keyes; Elizabeth Ogburn
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

5.  Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.

Authors:  Julian Santaella-Tenorio; Natalie S Levy; Luis E Segura; Pia M Mauro; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2019-10-16       Impact factor: 4.492

6.  Diagnostic orphans: adolescents with alcohol symptom who do not qualify for DSM-IV abuse or dependence diagnoses.

Authors:  N K Pollock; C S Martin
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

7.  Dependence symptoms but no diagnosis: diagnostic 'orphans' in a 1992 national sample.

Authors:  D Hasin; A Paykin
Journal:  Drug Alcohol Depend       Date:  1999-02-01       Impact factor: 4.492

8.  Alcohol use disorder diagnoses in the criminal justice system: an analysis of the compatibility of current DSM-IV, proposed DSM-5.0, and DSM-5.1 diagnostic criteria in a correctional sample.

Authors:  Albert M Kopak; Amanda V Metze; Norman G Hoffmann
Journal:  Int J Offender Ther Comp Criminol       Date:  2013-04-17

9.  The role of cannabis use within a dimensional approach to cannabis use disorders.

Authors:  Wilson M Compton; Tulshi D Saha; Kevin P Conway; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2008-12-04       Impact factor: 4.492

10.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

View more
  4 in total

1.  Cortical thickness and related depressive symptoms in early abstinence from chronic methamphetamine use.

Authors:  Johannes Petzold; Andy C Dean; Jean-Baptiste Pochon; Dara G Ghahremani; Richard De La Garza; Edythe D London
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

2.  HealthCall: A randomized trial assessing a smartphone enhancement of brief interventions to reduce heavy drinking in HIV care.

Authors:  Deborah S Hasin; Efrat Aharonovich; Barry S Zingman; Malka Stohl; Claire Walsh; Jennifer C Elliott; David S Fink; Justin Knox; Sean Durant; Raquel Menchaca; Anjali Sharma
Journal:  J Subst Abuse Treat       Date:  2022-01-31

3.  Validity of the DSM-5 craving criterion for alcohol, tobacco, cannabis, cocaine, heroin, and non-prescription use of prescription painkillers (opioids).

Authors:  D Shmulewitz; M Stohl; E Greenstein; S Roncone; C Walsh; E Aharonovich; M M Wall; D S Hasin
Journal:  Psychol Med       Date:  2021-11-01       Impact factor: 10.592

4.  Validity of the DSM-5 tobacco use disorder diagnostics in adults with problematic substance use.

Authors:  Dvora Shmulewitz; Eliana Greenstein; Malka Stohl; David S Fink; Stephanie Roncone; Claire Walsh; Efrat Aharonovich; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2022-03-17       Impact factor: 4.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.